ResearchMoz

Research Report on China's Diabetes Drug Market, 2013-2017

China Research and Intelligence Co., Ltd. (CRI)
Published Date » 2012-12-26
No. Of Pages » 50

Diabetes refers to a series of metabolic disorder syndrome such as sugars, proteins, fat, water and electrolyte that are triggered by islet dysfunction and insulin resistance, and the latter is caused by the actions of various pathogenic factors such as genetic factors, immune disorders, microbial infections and their toxins, free radical toxins, psychological factors on body. In recent years, with the development of China's economy and improvement in people's living standards, the incidence and morbidity rates of diabetes also present the increasing trend year by year.

In China, with the aggravation of aging degree, improvement in living standards and increase in obese groups caused by unhealthy lifestyles, the prevention and treatment of diabetes are increasingly severe. Since China carried out the first survey on diabetes epidemiology in 1980, the morbidity rate of diabetes increases from less than 1% then to about 10% currently. Following tumors and cardiovascular diseases, diabetes becomes the third-largest chronic disease severely threatening people's health. In 1994, diabetics only accounted for 2.5% of the population in China. This figure increased to 5.5% in 2002 and 9.7% in 2008.

In China, the diabetes morbidity rate of people aged above 20 has reached over 9.7%, and the morbidity rate of pre-diabetes (impaired fasting glucose and impaired glucose tolerance) has reached 15.5%. In developed regions of China, diabetics in the rural population are far less than that in the urban population. However, the morbidity rate of pre-diabetes, i.e., impaired glucose regulation, in the rural population is higher than that in the urban population, whether in developed or economically-backward areas. In economically-developed regions, the diabetes morbidity rate of the urban population is 13.6%, and that of the rural population is 16.6%. In medium-developed regions, the diabetes morbidity rate of the urban population is 15.6%, and that of the rural population is 20%. This also shows that, with the development of economy and changes in lifestyles, the rural population are potential groups who are more likely to suffer from diabetes.

Drug treatment is the focus of the treatment of diabetes. In addition to a small part of patients with type II diabetes which can be controlled through diet therapy and exercise therapy, the rest all need drug treatment. Diabetes drugs include Chinese patent drugs and western drugs, of which the latter is in a dominant position, while the former is in an auxiliary position in the treatment of diabetes.

With the increase in diabetes morbidity rate, residents' income levels and medical levels, the market size of China's diabetes drugs rises year by year, which always presents a rapidly growing trend in recent years, reaching CNY 15.86 billion in 2011, with an increase of 18.2% YOY.

In China, insulin preparations are always leaders in diabetes drug market, and the market share grows year by year recently, reaching 37.75% in 2011, with promising market prospects. Acarbose ranked the second. Before 2010, the share declined year after year, which slightly rebounded in 2011. Market shares of other varieties are all very low, which cannot threaten the market positions of insulin preparations and Acarbose.

The market size of China's diabetes drugs is expected to maintain an annual growth rate of over 18% from 2013 to 2017.

More following information can be acquired through this report:

  • Incidence of Diabetes in China
  • Market Situation of China's Hospital-use Diabetes Drugs
  • Competition in China's Diabetes Drug Market
  • Development Trends of Diabetes Treatment Technologies and Market in China 

Following people are recommended to buy this report:

  • Diabetes Drug Manufacturers
  • Pharmaceutical Trade Enterprises and Hospitals
  • Investors/Research Institutions Focusing on Diabetes Drugs
Table of Content

1 Overview on Diabetes Drug Market
1.1 Analysis on Diabetes Epidemiology
1.2 Brief Introduction and Classification of Diabetes Drugs

2 Global Diabetes Drug Market
2.1 New Diabetes Drugs Approved by U.S. FDA, 2011
2.2 Overview on Global Diabetes Drug Market

3 Overall Diabetes Drug Market in China
3.1 Market Size of China's Hospital-use Diabetes Drugs
3.2 Market Shares of Major Varieties of Hospital-use Diabetes Drugs
3.3 Market Shares of Diabetes Drug Manufacturers in Hospital-use Drugs
3.4 Concentration Rate of Diabetes Drug Market
3.5 Growth Rates of Major Varieties in Hospital-use Diabetes Drug Market

4 Analysis on Major Varieties in Diabetes Drug Market
4.1 Insulin Preparations
4.2 Acarbose
4.3 Metformin
4.4 Repaglinide
4.5 Glimepiride
4.6 Rosiglitazone
4.7 Gliclazide
4.8 Gliquidone
4.9 Nateglinide
4.10 Glipizide
4.11 Others

5 Major Diabetes Drugs and Prices in China, 2012

6 Development Trends of Diabetes Drugs

6.1 Market Size Trend
6.2 Technology Trend

List of Tables

NA

List of Figures


Chart Market Size of Global Diabetes Drugs, 2007-2011 
Chart Diabetes Drugs in Global Bestselling Drugs, 2011 
Chart Market Size of China's Hospital-use Diabetes Drugs, 2007-2012
Chart Top 20 Hospital-use Diabetes Drugs by Marker Share in China, 2007-2011 
Chart Top 20 Hospital-use Diabetes Drug Manufactures by Market Share in China, 2007-2011
Chart Market Concentration Rate of China's Hospital-use Diabetes Drugs, 2007-2011 
Chart Market Growth Rates of Top 20 Varieties of Hospital Diabetes Drugs in China, 2008-2011
Chart Market Size of China's Insulin Preparations in Hospital-use Drugs, 2007-2011
Chart Market Shares of China's Insulin Preparation Manufacturers in Hospital-use Drugs, 2011 
Chart Market Shares of China's Acarbose Enterprises in Hospital-use Drugs, 2011
Chart Market Shares of China's Metformin Manufacturers in Hospital-use Drugs, 2011
Chart Market Shares of China's Repaglinide Manufacturers in Hospital-use Drugs, 2011
Chart Prediction on Market Size of China's Anti-diabetic Hospital-use Drugs, 2013-2017

Upcoming Reports:

Flexible Electronics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Flexible electronics industry combines technical sectors such as polymers, advance materials, flexible displays and more. Each of these sectors are creating new applications in flexible electronics devices, which are applied in medical, advance energy, military, industrial and consumer markets. The flexible electronics industry is driven by the global need to create products which are small, light weight and consume less power. As such devices have flexible structure, low manufacturing cost and are more resistant to shock; they can be integrated with various industrial...
Asia Pacific Video Surveillance Market - Country Wise Forecast, Market Share, Trends & Analysis 2012 - 2018
By - Transparency Market Research
The Asia Pacific video surveillance market has shown remarkable progress in the recent years and is also showing attractive market potential for the future. Demand for video surveillance is increasing due to the rising demand for high quality images. Video surveillance has proved to be a huge crime deterrent and is being adopted by security and law enforcement agencies across the region. China has the dominating position in terms of market share in the Asia Pacific region followed by Japan and South Korea. The market in India holds immense growth opportunities owing to developments...
Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Forecast, Market Share, Size, Growth And Industry Analysis, 2012 - 2018
By - Transparency Market Research
Apheresis, also called as hemapheresis and pheresis is a procedure which involves withdrawal of blood from a donor and separation and retention of its components such as plasma, platelets, leukocytes, and others. Thereafter, the remaining components are transfused back into the donor.  Thus therapeutic apheresis is a procedure of separation of blood into its components and also includes removal of abnormal components. The overall apheresis market is classified from the perspective of donor apheresis and therapeutic apheresis. Increase in health awareness,...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014  
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies.  Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...